PTQ.V - Protech Home Medical Corp.

TSXV - TSXV Delayed Price. Currency in CAD
1.1500
+0.0300 (+2.68%)
At close: 3:59PM EDT
Stock chart is not supported by your current browser
Previous Close1.1200
Open1.1200
Bid1.1400 x 0
Ask1.1500 x 0
Day's Range1.1000 - 1.1500
52 Week Range0.4700 - 1.3500
Volume512,599
Avg. Volume546,406
Market Cap128.138M
Beta (5Y Monthly)2.98
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
All
News
Press Releases
  • GlobeNewswire

    Protech Home Medical Announces Closing of $31.8 Million Short Form Prospectus Offering (Including Full Exercise of the Over-Allotment Option) and Concurrent Private Placements

    Protech Home Medical Corp. (the “Company”) (PTQ.V) (PTQQF), a U.S.-based leader in the home medical equipment industry, focused on end-to-end respiratory care, is pleased to announce that it has closed its previously announced bought deal prospectus offering of ‎25,001,000 units (“Units”) at a price of $1.15 per Unit (the “Issue Price”) for aggregate gross proceeds of $28,751,150 (the “Public Offering”), which includes the exercise in full of the 15% over-allotment option. The syndicate of underwriters (the “Underwriters”) for the Public Offering was co-led by Beacon Securities ‎Limited (“Beacon”), as sole bookrunner, and Canaccord Genuity Corp. (“Canaccord”). The Units under the Public Offering were offered and sold by way of a short form prospectus filed in British Columbia, Alberta and Ontario.

  • GlobeNewswire

    Protech Home Medical Announces Filing of Final Prospectus

    Protech Home Medical Corp. (the “Company”) (PTQ.V) (PTQQF) is pleased to announce that is has filed its (final) short form prospectus in connection with its previously announced bought deal public offering (the “Offering”) of units (“Units”) of the Company conducted by a syndicate of underwriters (the “Underwriters”) co-led by Beacon Securities Limited, as sole bookrunner, and Canaccord Genuity Corp. Under the terms of the Offering, the Underwriters have agreed to purchase ‎21,740,000 Units from treasury of the Company, at a price of $1.15 per Unit for total gross proceeds of $‎25,001,000‎. Each Unit will consist of one common share of the Company (a “Common Share”) and one-half of one common share purchase warrant of the Company (each whole warrant, a “Warrant”).

  • GlobeNewswire

    Protech Home Medical Announces Filing of Preliminary Prospectus and Concurrent Private Placements

    Protech Home Medical Corp. (the “Company”) (PTQ.V) (PTQQF) is pleased to announce that it has filed the preliminary prospectus in connection with its previously announced bought deal public offering (the “Public Offering”) of units (“Units”) of the Company. In addition, the Company announces that it anticipates completing, concurrent with the Public Offering: (i) a brokered private placement of 1,750,000 Units (the “Brokered Private Placement”) conducted by a syndicate of agents (the “Agents”) led by Beacon Securities Limited (“Beacon”), as sole bookrunner, and Canaccord Genuity Corp., and (ii) a non-brokered private placement of 927,826 Units (the “Non-Brokered Private Placement”, and together with the Brokered Private Placement, the “Concurrent Private ‎Placements”), with Gregory Crawford, Chairman and CEO of the Company, and Mark Greenberg, a director of the Company.

  • CNW Group

    IIROC Trading Resumption - PTQ

    IIROC Trading Resumption - PTQ

  • CNW Group

    Protech Home Medical Announces $25 Million Bought Deal Offering

    CINCINNATI, OH, June 2, 2020 /CNW/ - Protech Home Medical Corp. (the "Company") (TSXV:PTQ.V - News) (OTCQX:PTQQF - News) is pleased to announce that it has entered into an agreement with a syndicate of underwriters  (the "Underwriters") co-led by Beacon Securities Limited ("Beacon"), as sole bookrunner, and Canaccord Genuity Corp. The Underwriters have agreed to purchase, on a bought deal basis pursuant to the filing of a short form prospectus, an aggregate of 21,740,000 units (the "Units") at a price of $1.15 per Unit (the "Issue Price") for aggregate gross proceeds to the Company of $25,001,000 (the "Offering"). Each Unit shall consist of one common share of the Company (a "Common Share") and one-half of one common share purchase warrant of the Company (each whole warrant, a "Warrant").

  • CNW Group

    IIROC Trading Halt - PTQ

    IIROC Trading Halt - PTQ

  • GlobeNewswire

    Protech Home Medical Announces Commencement of Trading on the OTCQX® Best Market in the United States

    Protech Home Medical Corp. (“Protech” or the “Company”) (PTQ.V) (PTQQF), a healthcare services company with operations in the U.S., today announced that it has qualified to trade on the OTCQX® Best Market. The common shares of Protech will commence trading at the open today on OTCQX under the symbol “PTQQF.” U.S. investors can find current financial disclosure and Real-Time Level 2 quotes for the company on www.otcmarkets.com.

  • ACCESSWIRE

    Protech Home Medical Corp. to Host Earnings Call

    NEW YORK, NY / ACCESSWIRE / May 20, 2020 / Protech Home Medical Corp. (TSXV:PTQ.V) will be discussing their earnings results in their 2020 Second Quarter Earnings call to be held on May 20, 2020 at 10:00 ...

  • GlobeNewswire

    Protech Home Medical Reports Record Second Quarter Fiscal 2020 Financial Results

    Protech Home Medical Corp. (“Protech” or the “Company”) (PTQ.V), a healthcare services company with operations in the U.S., today announced its second quarter fiscal 2020 financial results and operational highlights for the period ended March 31, 2020. The Company has taken the necessary steps to ensure the health and safety of our employees by providing them with the appropriate personal protective equipment for patient-facing employees. The Company’s supply chain for critical equipment has remained strong, and we continued to opportunistically build inventory to meet the increases in demand, particularly for ventilators and home oxygen equipment.

  • GlobeNewswire

    Protech Home Medical Announces Date and Time for Q2 2020 Conference Call and Audio Webcast

    CINCINNATI, May 07, 2020 -- Protech Home Medical Corp. (the “Company”) (TSXV: PTQ), a ‎healthcare services company with operations in the U.S., today announced that it will.

  • GlobeNewswire

    Protech Home Medical Announces Preliminary Second Quarter 2020 Results

    Protech Home Medical Corp. (the “Company” or “Protech”) (PTQ.V), a healthcare services company with operations in the U.S., is pleased to announce preliminary financial results for the second quarter of 2020, ending March 31, 2020. “These preliminary results are truly a testament to our employees, whom have shown extraordinary resilience in the face of the COVID-19 pandemic,” commented Greg Crawford, CEO, and Chairman of Protech. Although we do not normally provide preliminary results, and do not intend to moving forward, we felt that giving our shareholders a more real time update would assist in better understanding the current state of our business during this unusual period of time.

  • GlobeNewswire

    Protech Home Medical Secures $5.97 Million Loan Under Payroll Protection Provision of Cares Act

    Protech Home Medical Corp. (the “Company” or “Protech”) (PTQ.V), a healthcare services company with operations in the U.S., is pleased to announce that it has been approved for a CAD$5.97 million loan under the Payroll Protection Program (“PPP”) administered by the U.S. Small Business Administration. The PPP is a US$349 billion loan program that originated from the U.S. Coronavirus Aid, Relief and Economic Security (CARES) Act. As a U.S. Small Business, Protech qualifies for the PPP which allows businesses with fewer than 500 employees to obtain loans of up to US$10 million to assist companies in maintaining their workers through the COVID-19 pandemic.

  • GlobeNewswire

    Protech Home Medical Announces Continued Business Excellence During COVID-19 Pandemic and Comments on CMS Decision to Remove Non-Invasive Ventilators from Competitive Bidding Program

    Protech Home Medical Corp. (the “Company” or “Protech”) (PTQ.V), a healthcare services company with operations in the U.S., provides a further business update on its operations during the COVID-19 pandemic. Protech provides home delivery and efficient online set-up of equipment for, primarily, chronic conditions. The Company, based in the United States, operates out of 42 locations in 10 states with over 17,000 referring physicians and approximately 80,000 current active patients.

  • GlobeNewswire

    PROTECH HOME MEDICAL PROVIDES BUSINESS UPDATE IN RESPONSE TO COVID-19 VIRUS

    Protech Home Medical Corp. (the “Company” or “Protech”) (PTQ.V), a healthcare services company with operations in the U.S., provides the following business update in the face of the Covid-19 pandemic. Protech is on the front lines of providing home healthcare in its markets in the United States. To this point, the President’s guidelines for the next 15 days, issued on March 16, 2020, specifically noted that healthcare services are a critical infrastructure industry as defined by the Department of Homeland Security and employees of companies in this industry have a social responsibility to maintain a normal work schedule to meet service demands.

  • GlobeNewswire

    Protech Home Medical Reports Solid Q1 2020 Financial Results

    Protech Home Medical Corp. (the “Company”) (PTQ.V), a healthcare services company with operations in the U.S., today announced its first quarter fiscal 2020 financial results and operational highlights. Revenue for Q1 2020 was $22.8 million compared to $20.5 million for Q1 2019, representing an 11% increase in revenue year-over-year. Gross margin in Q1 2020 was 74%, up from 70% in Q1 2019 as a result of ongoing margin enhancement efforts including patient intake and distribution optimization.

  • GlobeNewswire

    Protech Home Medical is Proud to be Named to the 2020 TSX Venture 50 Group of Top Performing Companies

    Protech Home Medical Corp. (the “Company”) (PTQ.V), a ‎healthcare ‎services company with operations in the U.S., is pleased to announce it has been named to the 2020 TSX Venture 50™. This is the TSX Venture Exchange’s annual ranking of top performing companies on the TSX Venture Exchange. There are over of 1,600 companies listed on the TSX Venture Exchange.

  • GlobeNewswire

    Protech Home Medical Announces Date and Time for Q1 Fiscal 2020 Quarterly Conference Call

    CINCINNATI, Feb. 18, 2020 -- Protech Home Medical Corp. (the “Company”) (TSXV: PTQ), a ‎healthcare services company with operations in the U.S., today announced that it will.

  • GlobeNewswire

    Protech Home Medical Submits Application for Listing on the OTCQX® Best Market and Retains U.S. Capital Markets Advisory Firm

    NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREIN. CINCINNATI, Feb. 04, 2020 (GLOBE NEWSWIRE) -- Protech Home Medical Corp. (“Protech” or the “Company”) (PTQ.V), a healthcare services company with operations in the U.S., today announced that it has submitted its formal application  to have the Company’s shares quoted on the OTCQX® Best Market. Expanding to the OTCQX Best Market would provide existing shareholders with an additional trading platform to the TSX Venture Exchange in addition to introducing the Company to a broader range of institutional and retail investors in the U.S. In order to qualify for the OTCQX Best Market, issuers must meet high financial standards, follow best practice for corporate governance, demonstrate compliance with certain U.S. securities laws, be current in their disclosures, and have a professional third-party sponsor introduction.

  • GlobeNewswire

    Protech Home Medical Reports Solid Fourth Quarter and Audited Full Year Fiscal 2019 Financial Results

    Protech Home Medical Corp. (the “Company”) (PTQ.V), a healthcare services company with operations in the U.S., today announced its fourth quarter and audited full year fiscal 2019 financial results and operational highlights. Protech will host its Quarterly Earnings Conference Call on Wednesday, January 29, 2020 at 10:00 a.m. (EST). Full-year revenue for fiscal 2019 was $81.0 million compared to $70.5 million for fiscal 2018, representing a 15% increase in revenue year-over-year.

  • GlobeNewswire

    Protech Home Medical Announces Date and Time for Q4 and Full Year Fiscal 2019 Quarterly Conference Call

    NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREIN. CINCINNATI, Jan..

  • GlobeNewswire

    Protech Announces Accretive Acquisition of Acadia Medical, Inc. as the Company Nears $100 Million of Run Rate Revenue

    Protech Home Medical Corp. (“Protech” or the “Company”) (PTQ.V), a healthcare services company with operations in the U.S., is pleased to announce that it has acquired Acadia Medical, Inc. (“AMI”), a company based in Maine. AMI is a leader and top provider of respiratory services in the State of Maine. It currently has four locations and will allow Protech to further expand its geographical footprint and provide a larger number of services in the State of Maine.

  • GlobeNewswire

    Protech Home Medical Announces Highly Accretive Acquisition of Cooley Medical, Inc. and Update on Growing M&A Pipeline

    Protech Home Medical Corp. (“Protech” or the “Company”) (PTQ.V), a healthcare services company with operations in the U.S., is pleased to announce that it has acquired Cooley Medical, Inc. (“CMI”), a company based in Kentucky. CMI is a leader and top provider of respiratory services in Eastern and Central Kentucky with six locations that, when combined with the Company’s current operations, will significantly expand Protech’s geographical footprint and will provide services to an additional 34 counties in the state of Kentucky, eight in Indiana and five in Virginia. Under the terms of the definitive purchase agreement, Protech will acquire CMI for total cash consideration of approximately $3.1 million and the assumption of approximately $0.9 million of debt.

  • GlobeNewswire

    Protech Home Medical Provides Corporate Update

    Protech Home Medical Corp. (“Protech” or the “Company”) (TSXV: ‎PTQ), a healthcare services company with operations in the United States, today provides a corporate update including details regarding the return of stolen funds previously misappropriated pursuant to a cyberscam, the sale of a non-core asset, the strengthening of its executive team and the renewed emphasis on the Company’s strategic initiatives including its acquisition objectives. As press released on September 9, 2019, the Company is pleased to announce the return of CAD$8.6 million which had been misappropriated pursuant to a cyberscam incident originally announced on May 6, 2019. The funds have now been returned by the perpetrator’s bank pursuant to the final Garnishee Order Absolute announced by the Company on August 16, 2019.

  • GlobeNewswire

    Protech Home Medical Receives $8.6 Million

    Protech Home Medical Corp. (“Protech” or the “Company”) (TSXV: ‎PTQ), a healthcare services company with operations in the United States, is pleased to announce the return of CAD$8.6 million which had been stolen from the Company pursuant to a cyberscam originally announced by the Company in a press release dated May 6, 2019. The funds were returned to the Company by the bank of the perpetrator of the cyberscam pursuant to the final Garnishee Order Absolute, announced by the Company in a press release dated August 16, 2019. The Company provides in-home monitoring and disease management services for patients in the ‎United States healthcare market.

  • GlobeNewswire

    Protech Home Medical Reports Solid Third Quarter Fiscal 2019 Financial Results

    Protech Home Medical Corp. (the “Company”) (PTQ.V), a healthcare services company with operations in the U.S., today announced its third quarter financial results and operational highlights. Additionally, the Company has filed a claim under its insurance policy for costs related to this cyber-crime.